Magdalena Lukamowicz‐Rajska

Author

Also Known As

Magdalena Lukamowicz-Rajska, Magdalena Lukamowicz‐Rajska

Publications

152

Citations

H-Index

Concepts

All Affiliations

Magdalena Lukamowicz‐Rajska is an author at Novartis (Switzerland) specializing in cancer research, drug delivery systems, and lung cancer.

#	Concept	H-Index	Publications	Citations
1	Engineering	1	1	47
2	Medicine	1	1	47
3	Biomedical Engineering	1	1	47
4	Cell Biology	1	1	47
5	Pathology	1	1	47

Magdalena Lukamowicz‐Rajska

Publications

148

Citations

H-Index

Page 1

	Year	Citations
Co-assessment of cell cycle and micronucleus frequencies demonstrates the influence of serum on the<i>in vitro</i>genotoxic response to amorphous monodisperse silica nanoparticles of varying sizes Laetitia Gonzalez, Magdalena Lukamowicz‐Rajska, Leen C.J. Thomassen, Nanotoxicology NanoparticlesEngineeringPathologyNanotoxicologyCell Cycle	2013	47
Flow cytometric 96‐well microplate‐based in vitro micronucleus assay with human TK6 cells: Protocol optimization and transferability assessment Steven M. Bryce, Svetlana L. Avlasevich, Jeffrey C. Bemis, Environmental and Molecular Mutagenesis	2013	43
MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients Magdalena Lukamowicz‐Rajska, Christiane Mittmann, Michael Prummer, Oncotarget	2016	33
miR-30c-2-3p and miR-30a-3p: New Pieces of the Jigsaw Puzzle in HIF2α Regulation Holger Moch, Magdalena Lukamowicz‐Rajska Cancer Discovery	2014	14
Miniaturized flow cytometry‐based in vitro primary human lymphocyte micronucleus assay—validation study Magdalena Lukamowicz‐Rajska, Micheline Kirsch‐Volders, Willi Suter, Environmental and Molecular Mutagenesis	2012	11

Page 1